Ozempic is approved for type 2 diabetes and formulation-specific cardiovascular or kidney-risk contexts, not for chronic weight management
The research is active, evolving, and not settled - but it's consistent enough that leading endocrinologists are calling for musculoskeletal monitoring as a standard part of GLP-1 prescribing
It also has been reported to be helpful for healing damaged skin, burns, cuts, and healing of ulcers, damaged heart muscle, the digestive system, and the brain
So dietitians and nutritionists should also be prepared to integrate with other clinicians on a larger care team, looking at interventions to: Improve sleep quality Manage mental stress Nurture positive social connections Minimize other substance use The advisory also notes that this sort of structured, evidence-based therapy is not commonly in use with GLP-1 administration today, however